Thursday, July 11, 2013
Publication and contact
MAP kinase interacting serine-threonine kinase 1 (MKNK1;
translation initiation factor 4E (eIF4E)
In vitro and mouse studies suggest inhibiting MNK1 and MNK2
could help treat the blast crisis phase of CML by reducing eIF4E activation.
Self-renewal of granulocyte macrophage progenitors (GMPs) is associated with
blast crisis. In GMPs from patients with CML, MNK1 and MNK2 inhibition
decreased eIF4E activation and self-renewal capacity compared with no
inhibition. In xenograft mouse models for CML blast crisis, an MNK1 and MNK2
inhibitor decreased GMP engraftment compared with vehicle. Ongoing work
includes testing dual MNK and BCR-ABL
tyrosine kinase inhibitors in cellular and animal models
Pharmaceuticals Inc.'s ISIS-EIF4ERx,
a second-generation antisense oligonucleotide targeting eIF4E, is in Phase
I/II testing to treat non-small cell lung cancer (NSCLC) and prostate cancer.
Clavis Pharma ASA and Translational
Therapeutics Inc. have ribavirin
a Lipid Vector Technology derivative of ribavirin that inhibits eIF4E, in
preclinical testing to treat thyroid cancer.
Published online July 11, 2013
Unpatented; available for
Lim, S. et al. Proc.
Natl. Acad. Sci. USA; published online June 4, 2013;
Contact: S. Tiong Ong, Duke-NUS Graduate Medical School Singapore,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]